We are live on ! Find out more
UFF

USA Financial Formulas Portfolio holdings

AUM $531M
1-Year Est. Return 28.6%
This Fund
S&P 500
This Quarter Est. Return
+25.51%
1 Year Est. Return
+28.6%
3 Year Est. Return
+77.97%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$135M
AUM Growth
-$22.4M
Cap. Flow
-$46.8M
Cap. Flow %
-34.82%
Top 10 Hldgs %
38.49%
Holding
350
New
112
Increased
40
Reduced
54
Closed
93

Top Buys

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$4.38M
2
MNST icon
Monster Beverage
MNST
+$3.92M
3
DXCM icon
DexCom
DXCM
+$3M
4
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$2.59M
5
EA icon
Electronic Arts
EA
+$2.27M

Top Sells

Rank Stock Value
1
ANSS
Ansys
ANSS
+$3.85M
2
AMAT icon
Applied Materials
AMAT
+$3.56M
3
LRCX icon
Lam Research
LRCX
+$3.54M
4
BIIB icon
Biogen
BIIB
+$3.49M
5
FISV
Fiserv Inc
FISV
+$3.35M

Sector Composition

Rank Sector Weight
1 Healthcare 29.17%
2 Technology 24.33%
3 Communication Services 15.05%
4 Consumer Staples 8.01%
5 Real Estate 4.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CBOE icon
151
Cboe Global Markets
CBOE
$31.1B
$1K ﹤0.01%
7
– –
CINF icon
152
Cincinnati Financial
CINF
$27.3B
$1K ﹤0.01%
+12
New +$792
CL icon
153
Colgate-Palmolive
CL
$71.6B
$1K ﹤0.01%
+16
New +$1.14K
CMS icon
154
CMS Energy
CMS
$22.5B
$1K ﹤0.01%
20
– –
COST icon
155
Costco
COST
$423B
$1K ﹤0.01%
+4
New +$1.22K
CRM icon
156
Salesforce
CRM
$152B
$1K ﹤0.01%
+4
New +$674
CSCO icon
157
Cisco
CSCO
$457B
$1K ﹤0.01%
+16
New +$702
CTAS icon
158
Cintas
CTAS
$81.6B
$1K ﹤0.01%
+20
New +$1.16K
CVS icon
159
CVS Health
CVS
$134B
$1K ﹤0.01%
11
– –
DHI icon
160
D.R. Horton
DHI
$41B
$1K ﹤0.01%
14
-25,953
-100% -$1.26M
ETR icon
161
Entergy
ETR
$50.4B
$1K ﹤0.01%
14
-22,726
-100% -$1.1M
ETSY icon
162
Etsy
ETSY
$7.89B
$1K ﹤0.01%
+11
New +$814
EXC icon
163
Exelon
EXC
$47B
$1K ﹤0.01%
38
+27
+245% +$717
FAST icon
164
Fastenal
FAST
$55.2B
$1K ﹤0.01%
24
– –
FISV
165
Fiserv Inc
FISV
$29B
$1K ﹤0.01%
7
-33,252
-100% -$3.35M
FMC icon
166
FMC
FMC
$1.3B
$1K ﹤0.01%
8
-21,585
-100% -$1.99M
GEN icon
167
Gen Digital
GEN
$16.9B
$1K ﹤0.01%
+34
New +$692
GPC icon
168
Genuine Parts
GPC
$17.7B
$1K ﹤0.01%
+12
New +$948
GSK icon
169
GSK
GSK
$103B
$1K ﹤0.01%
+22
New +$1.13K
GWW icon
170
W.W. Grainger
GWW
$64.7B
$1K ﹤0.01%
+4
New +$1.16K
HPE icon
171
Hewlett Packard
HPE
$66.5B
$1K ﹤0.01%
+153
New +$1.5K
HRL icon
172
Hormel Foods
HRL
$13.9B
$1K ﹤0.01%
+29
New +$1.39K
HTLD icon
173
Heartland Express
HTLD
$949M
$1K ﹤0.01%
+59
New +$1.19K
IEX icon
174
IDEX
IEX
$17.2B
$1K ﹤0.01%
+8
New +$1.22K
JNPR
175
DELISTED
Juniper Networks
JNPR
$1K ﹤0.01%
+30
New +$690
5 6
7
8 9

Similar funds

EPA
Element Pointe Advisors Miami, Florida $530M AUM 16.87% 1-Year Est. Return
TM
Taproot Management New York $530M AUM
KI
Kapitalo Investimentos Sao Paulo, Brazil $531M AUM 25.72% 1-Year Est. Return
PWS
Proactive Wealth Strategies Marietta, Georgia $532M AUM 21.29% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
SLC
Second Line Capital Metairie, Louisiana $528M AUM 16.68% 1-Year Est. Return
LSCM
Light Street Capital Management Palo Alto, California $534M AUM 59.08% 1-Year Est. Return
LIM
Lathrop Investment Management Little Rock, Arkansas $534M AUM 22.94% 1-Year Est. Return

USA Financial Formulas's Q2 2020 Portfolio in Review

As of Q2 2020, USA Financial Formulas held 350 positions worth $135M, down 14% from $157M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

USA Financial Formulas withdrew a net $46.8M in Q2 2020, closing 93 positions and reducing 54 holdings. Its most notable exit was Gilead Sciences, an estimated $3.34M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 29% of assets, up from 15% a quarter earlier, followed by Technology and Communication Services.

Against the trend, USA Financial Formulas opened a new position in Johnson & Johnson worth $4.23M.

  • USA Financial Formulas's largest Q2 2020 buy was Johnson & Johnson: 30,087 shares worth $4.23M.
  • USA Financial Formulas added most to DexCom in Q2 2020, an estimated $3M increase.
  • USA Financial Formulas's biggest Q2 2020 reduction was Ansys, cutting an estimated $3.85M.
  • USA Financial Formulas fully exited Gilead Sciences in Q2 2020, selling an estimated $3.34M.
  • USA Financial Formulas's ten largest holdings make up 38% of its $135M portfolio in Q2 2020.
  • USA Financial Formulas opened 112 new positions and closed 93 in Q2 2020.
  • USA Financial Formulas's portfolio value fell 14% quarter-over-quarter to $135M.

Based on USA Financial Formulas's 13F filing for Q2 2020, filed 11 Aug 2020.